PlainPharmaWatch

CMS Open Payments · Program Year 2024

Acrotech Biopharma Inc.

Acrotech Biopharma Inc. reported $1,915,377.70 in payments to 1,589 physicians and teaching hospitals across 1,834 transactions.

See the rankings → How this is sourced
$1.9M
Total payments
1,834
Transactions
1,589
Recipients
−$83.6K
General Payments vs PY2023

Acrotech Biopharma Inc. reported $1,915,377.70 in payments to 1,589 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #458 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $1.2K per recipient across 8 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Acrotech Biopharma Inc. pairs top-quartile payment volume with a broadly spread payment pattern across many recipients.

#458
of 1,925 companies
0.0%
of all US industry payments
0.3%
paid to its single top recipient
8
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Acrotech Biopharma Inc.'s CMS-reported General Payments decreased by $83.6K (−20.8%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: ACROTECH BIOPHARMA INC.PY2023: ACROTECH BIOPHARMA INC.PY2024: Acrotech Biopharma Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$401.4KPY2024$317.9K
PY2023
$401,424.10
PY2024
$317,860.76

How Acrotech Biopharma Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Acrotech Biopharma Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$1,915,378 Top 24% higher than 76% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). This entry sits in this band. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Acrotech Biopharma Inc.

In Program Year 2024, Acrotech Biopharma Inc. reported $1,915,377.70 in payments to 1,589 physicians and teaching hospitals across 1,834 individual transactions, an average of $1.0K per transaction and $1.2K per recipient. That total places Acrotech Biopharma Inc. at rank #458 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

38 transactions worth $112.3K make "Consulting Fee" the top general-payment category in the 8-category breakdown below, 5.9% of the reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Acrotech Biopharma Inc. made 8 types of general payments. "Consulting Fee" is the largest category at $112.3K, 5.9% of the company's reported total.

How Acrotech Biopharma Inc. divides its payments

Ranked by total dollars reported per category

1. Consulting Fee$112.3K2. Grant$70.0K3. Compensation for Services…$40.8K4. Food and Beverage$36.3K5. Travel and Lodging$28.4K6. Space Rental or Facility …$26.8K7. Honoraria$3.3K8. Education$69.65
Payment Type Amount Transactions
Consulting Fee $112.3K 38
Grant $70.0K 1
Compensation for Services Other Than Consulting $40.8K 52
Food and Beverage $36.3K 1,393
Travel and Lodging $28.4K 89
Space Rental or Facility Fees $26.8K 9
Honoraria $3.3K 2
Education $69.65 5

Recipient Concentration in General Payments

The five largest recipient relationships account for $138,957.74 (43.7%) of $317,860.76 in this company's General Payments records across 1,097 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Acrotech Biopharma Inc.

The five named recipients with the highest reported General Payments from this company

University of Virginia Medic…$80.0KHayder Saeed$21.8KMatthew Lunning$14.8KFrancine Foss$13.2KJohn Glaspy$9.2K
  1. 1

    University of Virginia Medical Cente

    $80,000.01 across 4 reported transactions

  2. 2

    Hayder Saeed

    $21,769.62 across 9 reported transactions

  3. 3

    Matthew Lunning

    $14,795.95 across 16 reported transactions

  4. 4

    Francine Foss

    $13,200.74 across 8 reported transactions

  5. 5

    John Glaspy

    $9,191.42 across 8 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $1.0K. Average per recipient: $1.2K.

Total Amount

$1,915,377.70

Avg per Transaction

$1.0K

Avg per Recipient

$1.2K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Acrotech Biopharma Inc. Share

0.0%

#458 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Acrotech Biopharma Inc.

Applied Medical Resources Corporation

$1.9M 2,197 recipients

Vasorum USA Inc.

$1.9M 59 recipients

Spark Therapeutics, Inc.

$1.9M 146 recipients

Procyrion, Inc.

$1.9M 211 recipients

PROCEPT BioRobotics Corporation

$1.9M 8,013 recipients

CooperSurgical, Inc.

$1.9M 9,542 recipients

Frequently Asked Questions

How much did Acrotech Biopharma Inc. pay to physicians and hospitals in 2024? ▾
Acrotech Biopharma Inc. made $1,915,377.70 in payments to physicians and hospitals in Program Year 2024, across 1,834 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from Acrotech Biopharma Inc.? ▾
Acrotech Biopharma Inc. made payments to 1,589 physicians and teaching hospitals in 2024. The average payment per recipient was $1.2K.
What types of payments did Acrotech Biopharma Inc. make? ▾
8 categories of general payment make up Acrotech Biopharma Inc.'s reported activity, including consulting, meals, travel, and similar types. The largest general-payment category was "Consulting Fee" at $112.3K, representing 5.9% of the company's reported total.
How does Acrotech Biopharma Inc. rank among pharmaceutical companies? ▾
Acrotech Biopharma Inc. ranks #458 out of 1,925 companies by total payment amount in the CMS Open Payments database for 2024.
What is the average payment size from Acrotech Biopharma Inc.? ▾
In 2024, Acrotech Biopharma Inc. averaged $1.0K per transaction across 1,834 transactions to 1,589 recipients.
Where does the payment data for Acrotech Biopharma Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Acrotech Biopharma Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.